Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 2
1961 2
1962 2
1963 3
1964 3
1965 1
1966 2
1967 3
1968 4
1969 4
1970 5
1971 6
1972 4
1973 1
1974 4
1975 2
1976 6
1977 2
1978 3
1979 5
1980 2
1981 2
1982 1
1983 6
1984 3
1985 9
1986 5
1987 7
1988 4
1989 3
1990 6
1991 5
1992 3
1993 7
1994 11
1995 4
1996 5
1997 11
1998 11
1999 13
2000 5
2001 3
2002 2
2003 1
2004 1
2005 3
2006 6
2007 1
2008 4
2009 2
2010 1
2011 6
2012 12
2013 11
2014 13
2015 17
2016 10
2017 12
2018 24
2019 17
2020 24
2021 20
2022 15
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

374 results

Results by year

Filters applied: . Clear all
Page 1
Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study.
Chiba K, Okazaki N, Kurogi A, Watanabe T, Mori A, Suzuki N, Adachi K, Era M, Yokota K, Inoue T, Yabe Y, Furukawa K, Kondo C, Tsuda K, Ota S, Isobe Y, Miyazaki S, Morimoto S, Sato S, Nakashima S, Tashiro S, Yonekura A, Tomita M, Osaki M. Chiba K, et al. Among authors: yabe y. Bone. 2022 Jul;160:116416. doi: 10.1016/j.bone.2022.116416. Epub 2022 Apr 6. Bone. 2022. PMID: 35398293 Free article. Clinical Trial.
A splice-switching oligonucleotide treatment ameliorates glycogen storage disease type 1a in mice with G6PC c.648G>T.
Ito K, Tajima G, Kamisato C, Tsumura M, Iwamoto M, Sekiguchi Y, Numata Y, Watanabe K, Yabe Y, Kanki S, Fujieda Y, Goto K, Sogawa Y, Oitate M, Nagase H, Tsuji S, Nishizawa T, Kakuta M, Masuda T, Onishi Y, Koizumi M, Nakamura H, Okada S, Matsuo M, Takaishi K. Ito K, et al. Among authors: yabe y. J Clin Invest. 2023 Dec 1;133(23):e163464. doi: 10.1172/JCI163464. J Clin Invest. 2023. PMID: 37788110 Free PMC article.
Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models.
Nakazawa Y, Miyano M, Tsukamoto S, Kogai H, Yamamoto A, Iso K, Inoue S, Yamane Y, Yabe Y, Umihara H, Taguchi J, Akagi T, Yamaguchi A, Koga M, Toshimitsu K, Hirayama T, Mukai Y, Machinaga A. Nakazawa Y, et al. Among authors: yabe y. Nat Commun. 2024 Mar 11;15(1):2192. doi: 10.1038/s41467-024-46167-1. Nat Commun. 2024. PMID: 38467634 Free PMC article.
Fe-Catalyzed C-C Bond Construction from Olefins via Radicals.
Lo JC, Kim D, Pan CM, Edwards JT, Yabe Y, Gui J, Qin T, Gutiérrez S, Giacoboni J, Smith MW, Holland PL, Baran PS. Lo JC, et al. Among authors: yabe y. J Am Chem Soc. 2017 Feb 15;139(6):2484-2503. doi: 10.1021/jacs.6b13155. Epub 2017 Feb 2. J Am Chem Soc. 2017. PMID: 28094980 Free PMC article.
A practical and catalytic reductive olefin coupling.
Lo JC, Yabe Y, Baran PS. Lo JC, et al. Among authors: yabe y. J Am Chem Soc. 2014 Jan 29;136(4):1304-7. doi: 10.1021/ja4117632. Epub 2014 Jan 15. J Am Chem Soc. 2014. PMID: 24428607 Free PMC article.
374 results